Breakthrough bleeding with oral contraceptive use
- Authors: Savelyeva M.1, Nesterenko Z.2, Alekseeva A.2, Tachieva B.2
-
Affiliations:
- Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 29, No 8 (2018)
- Pages: 37-40
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117313
- DOI: https://doi.org/10.29296/25877305-2018-08-09
- ID: 117313
Cite item
Open Access
Access granted
Abstract
A questioning method was used to investigate the prevalence of breakthrough bleeding in reproductive-aged women taking combined oral contraceptives.
Full Text
About the authors
M. Savelyeva
Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
Email: marinasavelyeva@mail.ru
Professor
Z. Nesterenko
I.M. Sechenov First Moscow State Medical University (Sechenov University)
A. Alekseeva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
B. Tachieva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
References
- Weisberg E. A chewable low-dose oral contraceptive: a new birth control option? // Patient Prefer. Adherence. - 2012; 6: 355-60.
- Jensen J., Bitzer J., Serrani M. Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol // Open Access J. Contracept. - 2013; 4: 39-50.
- Black A., Francoeur D., Rowe T. et al. Canadian Contraception Consensus. SOGC Clinical Practice Guidelines, No.143-part 1, February 2004 // J. Obstet. Gynaecol. Can. - 2004; 26 (2): 143-56.
- Сметник В.П. Эстрогены: от синтеза до клинического применения / М.: Практическая медицина, 2012; с. 176.
- Grandi G., Napolitano A., Cagnacci A. Metabolic impact of combined hormonal contraceptives containing estradiol // Exp. Opin. Drug Metab. Toxicol. -2016; 12: 779-87.
- Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration // Climacteric. - 2005; 8 (Suppl. 1): 3-63.
- Jeyakumar M., Carlson K., Gunther J. et al. Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities // J. Biol. Chem. - 2011; 286: 12971-82.
- Государственный реестр лекарственных средств. [Электронный ресурс] URL: http://grls.rosminzdrav.ru/ (дата обращения 15.11.2017).
- Borek-Dohalska L., Valâskovâ P., Cerna V. et al. Role of rat cytochromes P450 in the oxidation of 17a-ethinylestradiol // Environ. Toxicol. Pharmacol. -2014; 38 (3): 852-60.
- World Health Organization (WHO). Medical eligibility criteria for contraceptive use. 4th ed. / Geneva, Switzerland: WHO; 2009.
- Савельева Г.М., Сухих Г.Т., Серова В.Н. и др. Гинекология. Национальное руководство / М.: ГЭОТАР-Медиа, 2017; с. 1048.
- Black A., Francoeur D., Rowe T. et al. Canadian Contraception Consensus. SOGC Clinical Practice Guidelines, No.329-part 4, April 2017 // J. Obstet. Gynaecol. Can. - 2017; 39 (4): 22968.
- Hapangama D., Bulmer J. Pathophysiology of heavy menstrual bleeding. // Womens Health (Lond). - 2016; 12: 3-13.
- Савельева М.И., Нестеренко З.А., Алексеева А.Ю. Роль комбинированных пероральных контрацептивов в патогенезе межменструальных кровотечений // Новые задачи современной медицины. - 2016; 53-5.
Supplementary files
